OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Navigating adalimumab biosimilars: an expert opinion
Vered Abitbol, Salim Benkhalifa, Caroline Habauzit, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 14
Vered Abitbol, Salim Benkhalifa, Caroline Habauzit, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 14
Showing 14 citing articles:
Analysis of biosimilars consumption in an Italian Local Health Authority
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 7
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 7
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design
J A Stevenson, Rachel Poker, Johanna Schoss, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115322-115322
Closed Access | Times Cited: 7
J A Stevenson, Rachel Poker, Johanna Schoss, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115322-115322
Closed Access | Times Cited: 7
Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
L. Puig
British Journal of Dermatology (2025)
Closed Access
L. Puig
British Journal of Dermatology (2025)
Closed Access
Comparing adalimumab biosimilars in the clinical practice of psoriatic patients
Domenico Giordano, Antonio Di Guardo, Annamaria Larosa, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Domenico Giordano, Antonio Di Guardo, Annamaria Larosa, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Biosimilars for the treatment of psoriasis: a narrative review
Duc Binh Phan, Z.Z.N. Yiu
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Duc Binh Phan, Z.Z.N. Yiu
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Monitoring analysis of the use of biosimilar medicines in the Campania region (southern Italy) to support effective and sustainable care
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme
Ran Jin, James Haughton, Emily J. Goddard, et al.
Rheumatology and Therapy (2025)
Open Access
Ran Jin, James Haughton, Emily J. Goddard, et al.
Rheumatology and Therapy (2025)
Open Access
Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan
Renata Maria Bianca Langfelder, Roberto Langella, Cinzia D’Angelo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 482-482
Open Access
Renata Maria Bianca Langfelder, Roberto Langella, Cinzia D’Angelo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 482-482
Open Access
The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access | Times Cited: 1
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access | Times Cited: 1
Highly ordered clustering of TNFα and BAFF ligand-receptor-adaptor complexes bound to lipid membranes
Chan Seok Lim, Jisun Lee, Ji Won Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Chan Seok Lim, Jisun Lee, Ji Won Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Efficacy, Safety and Persistence on Therapy after Non-medical Switching from Originator Adalimumab in IBD-Real Life Experience from Two Tertiary Centres
Popescu Remus, Teodora SPATARU, Monica State, et al.
(2024)
Open Access | Times Cited: 1
Popescu Remus, Teodora SPATARU, Monica State, et al.
(2024)
Open Access | Times Cited: 1
The Efficacy, Safety, and Persistence of Therapy after Non-Medical Switching from an Originator Adalimumab in Inflammatory Bowel Disease: Real-Life Experience from Two Tertiary Centres
Teodora SPATARU, Remus Popescu, Monica State, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1319-1319
Open Access | Times Cited: 1
Teodora SPATARU, Remus Popescu, Monica State, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1319-1319
Open Access | Times Cited: 1
Clinical outcomes of switching to adalimumab biosimilar (MSB11022) in patients with rheumatoid arthritis: RESTART Spanish Registry
Javier García-Miguel, Liliya Yankova Komsalova, Cristina Mata Arnaiz, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1431-1438
Closed Access
Javier García-Miguel, Liliya Yankova Komsalova, Cristina Mata Arnaiz, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1431-1438
Closed Access
Clinical experience of using biosimilars in Crohn’s disease and their effectiveness
Léa Sequier, Bénédicte Caron, Silvio Danese, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-25
Closed Access
Léa Sequier, Bénédicte Caron, Silvio Danese, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-25
Closed Access
